Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.92 USD | +7.37% | +28.53% | +182.22% |
May. 07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
May. 06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+182.22% | 724M | |
+39.64% | 50.93B | |
-0.20% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.00% | 26.02B | |
-22.48% | 18.9B | |
+8.62% | 13.21B | |
+24.55% | 12.17B | |
+29.74% | 12.16B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Cantor Fitzgerald Adjusts Price Target for Stoke Therapeutics to $38 From $68, Retains Overweight Rating